HIGHFDA DRUG
Dynarex Recalls Wecare Calasoothe Ointment Over cGMP Violations
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
MENTHOL AND ZINC OXIDE
cGMP deviations